Effect of Insulin Treatment on Prostacyclin in Experimental Diabetes

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1980 Jan 1

PMID 6988267

Citations 10

Authors

H E HARRISON

A H Reece

M Johnson

Affiliations

Soon will be listed here.

Abstract

Diabetic patients have a high susceptibility to microvascular complications, atherosclerosis and thrombosis. Platelet hyperreactivity possibly related to an imbalance in arachidonic acid metabolism may be involved. Aortic rings or renal cortex produced a potent inhibitor of platelet aggregation, identified as prostacyclin (PGI2). Release of PGI2 by tissues from streptozotocin -- diabetic rats (aorta: 0.07 +/ 0.1 ng/mg wet weight; renal cortex 0.004 +/- 0.001 ng/mg wet weight) was significantly depressed when compared with controls (aorta: 0.26 +/- 0.07 ng/mg wet weight; renal cortex: 0.009 +/- 0.001 ng/mg wet weight). Treatment of diabetic animals with insulin for 8 days restored PGI2 production to normal. The finding that PGI2 is depressed in the aorta and in the kidney, tissues which develop angiopathy, and that this is normalised by insulin, suggests that impaired PGI2 production, perhaps associated with platelet hyperreactivity may play a role in the vascular complications of diabetes.

Citing Articles

Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors.

Bugiardini R, Pavasovic S, Yoon J, van der Schaar M, Kedev S, Vavlukis M EClinicalMedicine. 2020; 27:100548.

PMID: 33150322 PMC: 7599315. DOI: 10.1016/j.eclinm.2020.100548.

The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation.

Carrizzo A, Izzo C, Oliveti M, Alfano A, Virtuoso N, Capunzo M Int J Mol Sci. 2018; 19(10).

PMID: 30274207 PMC: 6212935. DOI: 10.3390/ijms19102968.

Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Xu J, Zou M Circulation. 2009; 120(13):1266-86.

PMID: 19786641 PMC: 2910587. DOI: 10.1161/CIRCULATIONAHA.108.835223.

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Jackson J, BRESSLER R Drugs. 1981; 22(4):295-320.

PMID: 7030708 DOI: 10.2165/00003495-198122040-00003.

Production of 6-oxo-prostaglandin F1 alpha and prostaglandin E2 by isolated glomeruli from normal and diabetic rats.

Rogers S, Larkins R Br Med J (Clin Res Ed). 1982; 284(6324):1215-7.

PMID: 6803906 PMC: 1498117. DOI: 10.1136/bmj.284.6324.1215.

References

BREDDIN K, GRUN H, KRZYWANEK H, Schremmer W . On the measurement of spontaneous platelet aggregation. The platelet aggregation test III. Methods and first clinical results. Thromb Haemost. 1976; 35(3):669-91. View

Dusting G, Moncada S, Vane J . Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid. Prostaglandins. 1977; 13(1):3-15. DOI: 10.1016/0090-6980(77)90037-5. View

Herman A, Moncada S, Vane J . Formation of prostacyclin (PGl2) by different layers of the arterial wall. Arch Int Pharmacodyn Ther. 1977; 227(1):162-3. View

Preston F, Ward J, Marcola B, Porter N, Timperley W, OMalley B . Elevated beta-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet. 1978; 1(8058):238-40. DOI: 10.1016/s0140-6736(78)90483-x. View

Fox C, Darby S, Ireland J, Sonksen P . Blood glucose control and glomerular capillary basement membrane thickening in experimental diabetes. Br Med J. 1977; 2(6087):605-7. PMC: 1631551. DOI: 10.1136/bmj.2.6087.605. View

Hamberg M, Samuelsson B . Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proc Natl Acad Sci U S A. 1973; 70(3):899-903. PMC: 433384. DOI: 10.1073/pnas.70.3.899. View

NEEDLEMAN P, Moncada S, Bunting S, Vane J, Hamberg M, Samuelsson B . Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976; 261(5561):558-60. DOI: 10.1038/261558a0. View

GOODALE F, Daoud A, FLORENTIN R, Lee K, GITTELSOHN A . Chemico-anatomic studies of arteriosclerosis and thrombosis in diabetics. I. Coronary arterial wall thickness, thrombosis, and myocardial infarcts in autopsied North Americans. Exp Mol Pathol. 1962; 1:353-63. DOI: 10.1016/0014-4800(62)90030-8. View

Szczeklik A, Gryglewski R, Nizankowski R, Musial J, Pieton R, MRUK J . Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun. 1978; 10(6):545-56. DOI: 10.1016/s0031-6989(78)80053-8. View

10.

Keen H . Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention. Postgrad Med J. 1976; 52(609):445-51. PMC: 2496394. DOI: 10.1136/pgmj.52.609.445. View

11.

Takazakura E, Nakamoto Y, Hayakawa H, Kawai K, Muramoto S . Onset and progression of diabetic glomerulosclerosis; a prospective study based on serial renal biopsies. Diabetes. 1975; 24(1):1-9. DOI: 10.2337/diab.24.1.1. View

12.

Barham D, Trinder P . An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972; 97(151):142-5. DOI: 10.1039/an9729700142. View

13.

NEEDLEMAN P, Minkes M, Raz A . Thromboxanes: selective biosynthesis and distinct biological properties. Science. 1976; 193(4248):163-5. DOI: 10.1126/science.945611. View

14.

Johnson M, HARRISON H, Raftery A, Elder J . Vascular prostacyclin may be reduced in diabetes in man. Lancet. 1979; 1(8111):325-6. DOI: 10.1016/s0140-6736(79)90737-2. View

15.

Moncada S, Gryglewski R, Bunting S, Vane J . A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins. 1976; 12(5):715-37. DOI: 10.1016/0090-6980(76)90048-4. View

16.

Halushka P, Lurie D, Colwell J . Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med. 1977; 297(24):1306-10. DOI: 10.1056/NEJM197712152972402. View

17.

Ferguson J, Mackay N, Philip J, Sumner D . Determination of platelet and fibrinogen half-life with [75Se]selenomethionine: studies in normal and in diabetic subjects. Clin Sci Mol Med. 1975; 49(2):115-20. DOI: 10.1042/cs0490115. View

18.

Hamberg M, Svensson J, Samuelsson B . Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975; 72(8):2994-8. PMC: 432905. DOI: 10.1073/pnas.72.8.2994. View

19.

Bunting S, Moncada S, Reed P, Salmon J, Vane J . An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin. Prostaglandins. 1978; 15(4):565-73. DOI: 10.1016/0090-6980(78)90053-9. View

20.

Heath H, Brigden W, Canever J, Pollock J, Hunter P, Kelsey J . Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia. 1971; 7(5):308-15. DOI: 10.1007/BF01219463. View